Document is current
Any future updates will be listed below
-
Authors
Levy, Antonin https://orcid.org/0000-0003-4798-8899
Morel, Daphné
Texier, Matthieu
Rodriguez-Ruiz, Maria E.
Bouarroudj, Lisa
Bouquet, Fanny
Bustillos, Alberto
Quevrin, Clément
Clémenson, Céline
Mondini, Michele
Meziani, Lydia
Sun, Roger
Zaghdoud, Nadia
Tselikas, Lambros
Assi, Tarek
Faron, Matthieu
Honoré, Charles
Ngo, Carine
Verret, Benjamin
Le Péchoux, Cécile
Le Cesne, Axel
Ginhoux, Florent
Massard, Christophe
Bahleda, Rastilav
Deutsch, Eric
- License Information
-
More Information
Article History
Received: 24 September 2024
Revised: 6 February 2025
Accepted: 13 February 2025
First Online: 17 March 2025
Competing interests
: A.L. reports grants for academic research from PharMamar, Beigene, Amgen, Roche, and AstraZeneca outside of the submitted work. M.F. reports grants and personal fees from VIFOR Pharma and Pharmamar outside of the submitted work. M.M. reports grants from Boehringer Ingelheim outside of the submitted work. E.D. reports grants and personal fees from Roche-Genentech, AstraZeneca, Merck Serono, Boehringer, BMS, and MSD. R.S. declares research fundings from Daiichi Sankyo, Roche. and AstraZeneca outside of the submitted work. The other authors have nothing to declare.
